Clinical trial
TRANSFORM Heart Failure with Reduced Ejection Fraction
NCT04872959 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TRANSFORM Heart Failure with Reduced Ejection Fraction
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- October 22, 2021
- Completion date
- May 31, 2024
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.